Genetic Technologies: Funding, Investors & Team (Sep 2026)
Genetype: Key to individualised preventive health Genetic Technologies is a pioneer in the creation and commercialization of genetic risk assessment technologies (ASX: GTG, NASDAQ Global Market: GENE). Understanding the importance of inherited risk in chronic disease has advanced significantly, although many chronic disorders cannot be predicted by this risk alone. We are changing the dialogue. One-size-fits-all models are being replaced by personalised, predictive health assessments, where each person has the knowledge necessary to manage their health in accordance with their specific risk. Our doctors, scientists, and technicians are incorporating genetic information into many tests that specifically combine genetic and clinical risk models to forecast the risk of chronic diseases before they manifest, backed by more than 20 years of experience.
Genetic Technologies has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Feb 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genetic Technologies Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Genetic Technologies Funding Rounds
Genetic Technologies Founders and Leadership Team
No contact details are on record for this team yet.
Genetic Technologies Funding Compared to Other Biotechnology Startups
Genetic Technologies' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genetic Technologies in Biotechnology and Fitzroy
Companies Similar to Genetic Technologies
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Genetic Technologies Funding FAQs
What does Genetic Technologies do?
Genetype: Key to individualised preventive health Genetic Technologies is a pioneer in the creation and commercialization of genetic risk assessment technologies (ASX: GTG, NASDAQ Global Market: GENE). Understanding the importance of inherited risk in chronic disease has advanced significantly, although many chronic disorders cannot be predicted by this risk alone. We are changing the dialogue. One-size-fits-all models are being replaced by personalised, predictive health assessments, where each person has the knowledge necessary to manage their health in accordance with their specific risk. Our doctors, scientists, and technicians are incorporating genetic information into many tests that specifically combine genetic and clinical risk models to forecast the risk of chronic diseases before they manifest, backed by more than 20 years of experience.
How much funding has Genetic Technologies raised?
Genetic Technologies has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Feb 2023.
When did Genetic Technologies last raise funding?
Genetic Technologies' most recent funding round on record is an undisclosed round of $5.0M, announced in Feb 2023.
Who founded Genetic Technologies?
FundedIQ lists Simon M (Founder) at Genetic Technologies.
Where is Genetic Technologies headquartered?
Genetic Technologies is based in Fitzroy, Victoria, Australia.
How many employees does Genetic Technologies have?
Genetic Technologies is in the 101-250 employee band.
How does Genetic Technologies' funding compare to other Biotechnology startups?
Genetic Technologies' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Genetic Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genetic Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.